Theranos was one of a handful of so-called “unicorns,” a Silicon Valley term for startup companies with a valuation of at least $1 billion.
Steven Artandi, M.D., Ph.D. was appointed director of the Stanford Cancer Institute — an initiative that aims to improve cancer treatment at Stanford — on Oct. 1. He was previously a professor of medicine and biochemistry at the School of Medicine and will succeed outgoing director Beverly Mitchell, M.D., who has led the Institute for the past 10 years.
Researchers at the Stanford University School of Medicine and artificial intelligence company Unanimous AI found in a study that “swarm intelligence” technology is better at diagnosing pneumonia through chest X-ray scans than any individual doctor or computer working alone.
According to a March perspective piece by three Stanford researchers in the New England Journal of Medicine, while there is tremendous potential for machine learning to aid in expanded electronic records, efficient data-mining and health monitoring, there are also relevant challenges that may hinder the efficacy of machine learning systems in medical practice.
It may seem unlikely that studying the mechanics of concrete would inform brain research. However, Ellen Kuhl, mechanical engineering professor and head researcher for the Living Matter Lab, started out studying the molecular interactions of concrete and is now applying this understanding to the field of neuroscience, where her research has led to groundbreaking discoveries about neurological disorders.
Researchers at Stanford have developed a machine learning algorithm, CheXNet, to perform pneumonia diagnosis. In clinical tests, the algorithm performed accurate diagnosis at slightly better rates than doctors.